| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |